National Institutes of Health · Department of Health and Human Services
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
Key facts
- Deadline
- Due Aug 11, 2027 · 309 days left
- Award size
- Up to $150K
- Total available
- $150K
- Cost share / match ?
- Not required
- Who can apply
- County government, Public college or university, Other (see eligibility), Small business, Tribal organization, School district, Tribal government, State government, Special district (utility, fire, etc.), City or town government, Nonprofit with 501(c)(3), Private college or university, Larger business, Nonprofit without 501(c)(3)
- Where
- Anywhere in the U.S., including Tennessee
Before you apply: federal grants require an active SAM.gov registration (Unique Entity ID) and a Grants.gov account. Registration is free but can take weeks, so start now, not when the deadline is close. Grant-ready checklist
How this fits you
- Available in Tennessee (nationwide program)
- No cost share required
- Tennessee recipients since 2023: 19
Tell us who you are to see whether you're eligible.
More from National Institutes of Health
- Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed) · Forecast — the expected date (Jul 15, 2025) has passed; watch for the official notice
- IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed) · Forecast — the expected date (Jul 15, 2025) has passed; watch for the official notice
- Forecast to Renew the Notice of Funding Opportunity Announcement for the Multiple Chronic Disease Research Centers · Forecast — the expected date (Jul 25, 2025) has passed; watch for the official notice
- Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed) · Forecast — the expected date (Aug 22, 2025) has passed; watch for the official notice
- Forecast to Publish a Funding Opportunity Announcement for the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Research Resource (Collaborative U24 - Clinical Trials not allowed) · Forecast — the expected date (Sep 30, 2025) has passed; watch for the official notice
- Forecast to Publish a Funding Opportunity Announcement for the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Administrative Resource (Collaborative U24 - Clinical Trials not allowed) · Forecast — the expected date (Sep 30, 2025) has passed; watch for the official notice
Official notice: https://simpler.grants.gov/opportunity/bab9ddd0-0fd0-4153-b023-115f0d286991 · Printed from grantme.click/grants/d0d117a7-6ad7-4498-912a-f79ce6de2a99
Read the official notice View on Grants.gov Add deadline to my calendar Sign in to save
About this grant
The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is sparse or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.
Eligibility (from the notice)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Who in Tennessee has won this program
19 awards to Tennessee recipients in 4 counties since federal FY2023. Largest shown:
| Recipient | Where | Amount | FY |
|---|---|---|---|
| Vanderbilt University Medical Center | Nashville, Davidson County | $4.5M | 2016 |
| Vanderbilt University Medical Center | Nashville, Davidson County | $4.4M | 2023 |
| Vanderbilt University Medical Center | Nashville, Davidson County | $4M | 2022 |
| University Of Tennessee | Memphis, Shelby County | $3.9M | 2017 |
| Meharry Medical College | Nashville, Davidson County | $3.7M | 2022 |
| University Of Tennessee | Knoxville, Knox County | $3.5M | 2019 |
| University Of Tennessee | Memphis, Shelby County | $3.4M | 2021 |
| University Of Tennessee | Memphis, Shelby County | $3.1M | 2019 |
| St Jude Children'S Research Hospital Inc | Memphis, Shelby County | $3.1M | 2022 |
| University Of Tennessee | Memphis, Shelby County | $3.1M | 2022 |
| University Of Tennessee | Memphis, Shelby County | $3M | 2023 |
| Vanderbilt University Medical Center | Nashville, Davidson County | $2.9M | 2019 |
Source: USAspending.gov. Past awards show who this program funds; they don't guarantee future awards.
About the program (93.279)
Drug Use and Addiction Research Programs
How applications are judged
The following considerations will be used in determining projects to be funded: (1) Scientific and technical merit; (2) the feasibility of the research; (3) potential contribution to the national drug abuse problem; and (4) relevance to NIDA priorities. The following criteria will be used in considering the scientific and technical merit of SBIR/STTR Phase I grant applications: (1) The soundness and technical merit of the proposed approach; (2) the qualifications of the proposed principal investigator, supporting staff, and consultants; (3) the technological innovation of the proposed research; (4) the potential of the proposed research for commercial application; (5) the appropriateness of the budget requested; (6) the adequacy and suitability of the facilities and research environment; and (7) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects and/or (b) protecting against or minimizing any adverse effect on the environment. Phase II grant applications will be reviewed based upon the following criteria: (1) The degree to which the Phase I objectives were met and feasibility demonstrated; (2) the scientific and technical merit of the proposed approach for achieving the Phase II objectives; (3) the qualifications of the proposed principal investigator, supporting staff, and consultants; (4) the technology.
Matching requirements
This program has no statutory formula.
Matching requirements are not applicable to this assistance listing.
MOE requirements are not applicable to this assistance listing.
Examples of funded projects
Not Applicable.